Search results
10 hours ago · (Reuters) -GSK's shares fell as much as 7% on Thursday, a day after a U.S. public health agency narrowed its usage recommendation for all respiratory syncytial virus (RSV) vaccines and held off on ...
10 hours ago · GSK had expected Arexvy to generate annual sales of more than 3 billion pounds ($3.79 billion) over time. Arexvy clocked 1.2 billion pounds of sales last year when it was launched. ($1 = 0.7914 ...
10 hours ago · GSK's London-listed shares (UK:GSK) were trading at GBP14.91 in early action Thursday, a decline of 7%, and worse than the GBP15.44 implied by the U.S. close. Put a different way, the ADRs (GSK ...
10 hours ago · LONDON, June 27 (Reuters) - GSK shares fell by as much as 7.2% on Thursday, a day after the U.S. CDC narrowed its recommendation for use of respiratory syncytial virus (RSV) vaccines in older ...
10 hours ago · GSK stock recovered some of the losses and was down 4.4% at the time of writing. ... Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial ...
3 hours ago · Company Profile. GSK plc is a global biopharma company. The Companyâ s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine.
People also ask
Why did GSK stock fall 7% on Thursday?
What is the share price of GSK?
What's going on with GSK's stock?
What is the dividend yield on GSK shares?
Why did the GSK share price drop in March 2022?
Why did GSK stock drop 44%?
10 hours ago · (Reuters) -GSK's shares slid more than 6% on Thursday, a day after a U.S. public health agency narrowed its usage